Jason Haddock
2018
In 2018, Jason Haddock earned a total compensation of $1.8M as Chief Financial Officer at Array BioPharma, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,375 |
|---|---|
| Option Awards | $932,906 |
| Salary | $377,770 |
| Stock Awards | $305,760 |
| Other | $18,589 |
| Total | $1,828,400 |
Haddock received $932.9K in option awards, accounting for 51% of the total pay in 2018.
Haddock also received $193.4K in non-equity incentive plan, $377.8K in salary, $305.8K in stock awards and $18.6K in other compensation.
Rankings
In 2018, Jason Haddock's compensation ranked 6,191st out of 14,244 executives tracked by ExecPay. In other words, Haddock earned more than 56.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,191 out of 14,244 | 57th |
Division Manufacturing | 2,366 out of 5,765 | 59th |
Major group Chemicals And Allied Products | 886 out of 2,128 | 58th |
Industry group Drugs | 742 out of 1,817 | 59th |
Industry Pharmaceutical Preparations | 578 out of 1,391 | 58th |
Source: SEC filing on September 14, 2018.
Haddock's colleagues
We found four more compensation records of executives who worked with Jason Haddock at Array BioPharma in 2018.